| Número de catálogo | HB941016 |
| Especie huésped | Humanized |
| Reactividad de especies | Human |
| Forma | Liquid |
| Buffer de almacenamiento | 0.01M PBS, pH 7.4. |
| Pureza | >95% purity as determined by SDS-PAGE. |
| Clonalidad | Monoclonal |
| Isotipo | Fab-G1-kappa |
| Aplicaciones | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Objetivo | Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A |
| Purificación | Protein L purified from cell culture supernatant. |
| Nivel de endotoxinas | Please contact the lab for this information. |
| Sistema de expresión | Mammalian Cells |
| Número de acceso | P15692 |
| Estabilidad y almacenamiento | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | Fab-12variantY0317, RhuFab, 347396-82-1 |
| Nota | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Ranibizumab
Vista general
Descripción
Ranibizumab (HB941016) is a research-grade recombinant antibody targeting Vascular endothelial growth factor A. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Imágenes
 Bioactivity |
Detects Human VEGFA in indirect ELISAs. |
 SDS-PAGE |
SDS-PAGE for Research Grade Ranibizumab. |